21350020|t|Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease.
21350020|a|Microglial activation is an invariant feature of Alzheimer's disease (AD). It is noteworthy that cannabinoids are neuroprotective by preventing beta-amyloid (Abeta)-induced microglial activation both in vitro and in vivo. On the other hand, the phytocannabinoid cannabidiol (CBD) has shown anti-inflammatory properties in different paradigms. In the present study, we compared the effects of CBD with those of other cannabinoids on microglial cell functions in vitro and on learning behavior and cytokine expression after Abeta intraventricular administration to mice. CBD, (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl) pyrrolo-[1,2,3-d,e]-1,4-benzoxazin-6-yl]-1-naphthalenyl-methanone [WIN 55,212-2 (WIN)], a mixed CB(1)/CB(2) agonist, and 1,1-dimethylbutyl-1-deoxy-Delta(9)-tetrahydrocannabinol [JWH-133 (JWH)], a CB(2)-selective agonist, concentration-dependently decreased ATP-induced (400 muM) increase in intracellular calcium ([Ca(2+)](i)) in cultured N13 microglial cells and in rat primary microglia. In contrast, 4-[4-(1,1-dimethylheptyl)-2,6-dimethoxyphenyl]-6,6-dimethyl-bicyclo[3.1.1]hept-2-ene-2-methanol [HU-308 (HU)], another CB(2) agonist, was without effect. Cannabinoid and adenosine A(2A) receptors may be involved in the CBD action. CBD- and WIN-promoted primary microglia migration was blocked by CB(1) and/or CB(2) antagonists. JWH and HU-induced migration was blocked by a CB(2) antagonist only. All of the cannabinoids decreased lipopolysaccharide-induced nitrite generation, which was insensitive to cannabinoid antagonism. Finally, both CBD and WIN, after subchronic administration for 3 weeks, were able to prevent learning of a spatial navigation task and cytokine gene expression in beta-amyloid-injected mice. In summary, CBD is able to modulate microglial cell function in vitro and induce beneficial effects in an in vivo model of AD. Given that CBD lacks psychoactivity, it may represent a novel therapeutic approach for this neurological disease.
21350020	0	11	Cannabidiol	Chemical	MESH:D002185
21350020	22	34	cannabinoids	Chemical	MESH:D002186
21350020	99	118	Alzheimer's disease	Disease	MESH:D000544
21350020	169	188	Alzheimer's disease	Disease	MESH:D000544
21350020	190	192	AD	Disease	MESH:D000544
21350020	217	229	cannabinoids	Chemical	MESH:D002186
21350020	278	283	Abeta	Gene	11820
21350020	365	381	phytocannabinoid	Chemical	-
21350020	382	393	cannabidiol	Chemical	MESH:D002185
21350020	395	398	CBD	Chemical	MESH:D002185
21350020	415	427	inflammatory	Disease	MESH:D007249
21350020	512	515	CBD	Chemical	MESH:D002185
21350020	536	548	cannabinoids	Chemical	MESH:D002186
21350020	642	647	Abeta	Gene	11820
21350020	683	687	mice	Species	10090
21350020	689	692	CBD	Chemical	MESH:D002185
21350020	815	827	WIN 55,212-2	Chemical	MESH:C070417
21350020	829	832	WIN	Chemical	MESH:C113565
21350020	844	849	CB(1)	Gene	12801
21350020	850	855	CB(2)	Gene	12802
21350020	869	924	1,1-dimethylbutyl-1-deoxy-Delta(9)-tetrahydrocannabinol	Chemical	-
21350020	926	933	JWH-133	Chemical	MESH:C432747
21350020	935	938	JWH	Chemical	-
21350020	944	949	CB(2)	Gene	12802
21350020	1005	1008	ATP	Chemical	MESH:D000255
21350020	1053	1060	calcium	Chemical	MESH:D002118
21350020	1063	1069	Ca(2+)	Chemical	-
21350020	1087	1090	N13	CellLine	CVCL:5G93
21350020	1115	1118	rat	Species	10116
21350020	1151	1246	4-[4-(1,1-dimethylheptyl)-2,6-dimethoxyphenyl]-6,6-dimethyl-bicyclo[3.1.1]hept-2-ene-2-methanol	Chemical	-
21350020	1248	1254	HU-308	Chemical	MESH:C402416
21350020	1256	1258	HU	Chemical	MESH:D006918
21350020	1270	1275	CB(2)	Gene	12802
21350020	1305	1316	Cannabinoid	Chemical	MESH:D002186
21350020	1370	1373	CBD	Chemical	MESH:D002185
21350020	1382	1385	CBD	Chemical	MESH:D002185
21350020	1391	1394	WIN	Chemical	MESH:C113565
21350020	1447	1452	CB(1)	Gene	12801
21350020	1460	1465	CB(2)	Gene	12802
21350020	1479	1482	JWH	Chemical	-
21350020	1487	1489	HU	Chemical	MESH:D006918
21350020	1525	1530	CB(2)	Gene	12802
21350020	1559	1571	cannabinoids	Chemical	MESH:D002186
21350020	1582	1600	lipopolysaccharide	Chemical	MESH:D008070
21350020	1609	1616	nitrite	Chemical	MESH:D009573
21350020	1654	1665	cannabinoid	Chemical	MESH:D002186
21350020	1692	1695	CBD	Chemical	MESH:D002185
21350020	1700	1703	WIN	Chemical	MESH:C113565
21350020	1863	1867	mice	Species	10090
21350020	1881	1884	CBD	Chemical	MESH:D002185
21350020	1992	1994	AD	Disease	MESH:D000544
21350020	2007	2010	CBD	Chemical	MESH:D002185
21350020	2088	2108	neurological disease	Disease	MESH:D020271
21350020	Positive_Correlation	MESH:D000255	MESH:D002118
21350020	Negative_Correlation	MESH:D002185	12801
21350020	Negative_Correlation	MESH:C070417	MESH:D000255
21350020	Association	MESH:D002186	MESH:D000544
21350020	Association	MESH:D002185	MESH:D000544
21350020	Positive_Correlation	MESH:C113565	12802
21350020	Positive_Correlation	MESH:C402416	12802
21350020	Negative_Correlation	MESH:D002186	MESH:D009573
21350020	Association	MESH:D000255	12802
21350020	Negative_Correlation	MESH:D002185	MESH:D007249
21350020	Negative_Correlation	MESH:D000255	MESH:D002185
21350020	Negative_Correlation	MESH:C432747	MESH:D000255
21350020	Positive_Correlation	MESH:D008070	MESH:D009573
21350020	Positive_Correlation	MESH:C432747	12802
21350020	Positive_Correlation	MESH:C070417	12801
21350020	Positive_Correlation	MESH:C113565	12801
21350020	Positive_Correlation	MESH:C070417	12802
21350020	Negative_Correlation	MESH:C070417	MESH:D002118
21350020	Negative_Correlation	MESH:D002186	MESH:D008070
21350020	Positive_Correlation	MESH:D006918	12802
21350020	Positive_Correlation	MESH:D002185	12802
21350020	Negative_Correlation	MESH:D002118	MESH:D002185
21350020	Negative_Correlation	MESH:C432747	MESH:D002118
21350020	Negative_Correlation	MESH:D002186	11820

